Notwithstanding big-name lawyers and amicus support, E.I. du Pont de Nemours failed to convince the U.S. Supreme Court to review a lower court ruling against it in multidistrict litigation over a cancer-causing “forever chemical” known as C-8.

Denying DuPont’s petition for review Monday, the Supreme Court left in place the U.S. Court of Appeals for the Sixth Circuit’s affirmance of a judgment for a man who claimed his testicular cancer resulted from exposure to C-8 that the chemical company released into the environment.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]